Otsuka Holdings
4578.T
#702
Rank
S$44.21 B
Marketcap
S$83.74
Share price
-1.55%
Change (1 day)
34.87%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: S$1.34 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are S$14.47 Billion. In 2023 the company made an earning of S$1.34 Billion a decrease over its 2022 earnings that were of S$1.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023S$1.34 B-20.93%
2022S$1.69 B-12.7%
2021S$1.94 B-19.92%
2020S$2.42 B13.9%
2019S$2.13 B52.07%
2018S$1.40 B11.22%
2017S$1.25 B-36.03%
2016S$1.96 B31.15%
2015S$1.50 B
2013S$3.11 B33.52%
2012S$2.33 B-4.65%
2011S$2.44 B45.53%
2010S$1.68 B